ADAR1 Capital Management
Latest statistics and disclosures from ADAR1 Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALNY, BOXX, ROIV, SPY, PTGX, and represent 40.12% of ADAR1 Capital Management's stock portfolio.
- Added to shares of these 10 stocks: BOXX (+$34M), ALNY (+$28M), SPY (+$27M), PTGX (+$17M), ROIV (+$16M), BBIO (+$11M), CYTK (+$11M), Merrimack Pharma (+$5.2M), AVRO, BGNE.
- Started 124 new stock positions in ACET, MORF, OPCH, PHVS, AUPH, ADVM, MLTX, Kiora Pharmaceuticals, Ngm Biopharmaceuticals, VRDN.
- Reduced shares in these 10 stocks: KROS (-$23M), VKTX (-$20M), RPRX (-$18M), MRK (-$7.1M), Mirati Therapeutics (-$6.3M), ABUS, CERE, Karuna Therapeutics Ord, CLRB, Alteryx.
- Sold out of its positions in ANIP, Alpine Immune Sciences, ALT, Alteryx, ANEB, ARGX, Flamel Technologies Sa, BCLI, CETU, CLNN.
- ADAR1 Capital Management was a net buyer of stock by $127M.
- ADAR1 Capital Management has $441M in assets under management (AUM), dropping by 57.52%.
- Central Index Key (CIK): 0001940272
Tip: Access up to 7 years of quarterly data
Positions held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for ADAR1 Capital Management
ADAR1 Capital Management holds 247 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Alnylam Pharmaceuticals (ALNY) | 14.4 | $64M | +78% | 426k | 149.45 |
|
Ea Series Trust Alpha Arch 1-3 (BOXX) | 7.7 | $34M | NEW | 318k | 106.46 |
|
Roivant Sciences SHS (ROIV) | 6.7 | $29M | +121% | 2.8M | 10.54 |
|
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 6.2 | $27M | NEW | 52k | 523.07 |
|
Protagonist Therapeutics (PTGX) | 5.2 | $23M | +291% | 786k | 28.93 |
|
Cytokinetics Com New (CYTK) | 5.1 | $23M | +90% | 322k | 70.11 |
|
Keros Therapeutics (KROS) | 5.1 | $22M | -50% | 338k | 66.20 |
|
Royalty Pharma Shs Class A (RPRX) | 5.0 | $22M | -45% | 721k | 30.37 |
|
Bridgebio Pharma (BBIO) | 3.9 | $17M | +197% | 551k | 30.92 |
|
Merrimack Pharmaceuticals In Com New | 3.0 | $13M | +64% | 902k | 14.77 |
|
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.7 | $7.3M | +5% | 49k | 151.17 |
|
Arbutus Biopharma (ABUS) | 1.2 | $5.4M | -43% | 2.1M | 2.58 |
|
Avrobio Ord (AVRO) | 1.1 | $5.1M | +7786% | 4.0M | 1.28 |
|
Beigene Sponsored Adr (BGNE) | 1.1 | $4.9M | +1453% | 32k | 156.39 |
|
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 1.0 | $4.4M | NEW | 10k | 444.01 |
|
Alkermes SHS (ALKS) | 1.0 | $4.2M | NEW | 157k | 27.07 |
|
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 1.0 | $4.2M | NEW | 404k | 10.40 |
|
Sarepta Therapeutics (SRPT) | 0.9 | $4.2M | +300% | 32k | 129.46 |
|
Endeavor Group Hldgs Cl A Com (EDR) | 0.9 | $4.0M | +6110% | 155k | 25.73 |
|
Achieve Life Sciences (ACHV) | 0.9 | $4.0M | NEW | 875k | 4.54 |
|
Fusion Pharmaceuticals | 0.9 | $3.8M | NEW | 177k | 21.32 |
|
Absci Corp (ABSI) | 0.8 | $3.3M | NEW | 587k | 5.68 |
|
Applied Therapeutics (APLT) | 0.8 | $3.3M | NEW | 487k | 6.80 |
|
Edgewise Therapeutics (EWTX) | 0.7 | $3.3M | NEW | 181k | 18.24 |
|
Fulcrum Therapeutics (FULC) | 0.7 | $3.2M | -46% | 340k | 9.44 |
|
Q32 Bio (QTTB) | 0.7 | $3.2M | NEW | 188k | 17.04 |
|
Cerevel Therapeutics Hldng I (CERE) | 0.7 | $3.1M | -53% | 75k | 42.27 |
|
Spdr Ser Tr Bloomberg 1-3 Mo (BIL) | 0.7 | $3.0M | 33k | 91.80 |
|
|
Pfizer (PFE) | 0.7 | $3.0M | +76% | 106k | 27.75 |
|
Vanguard Bd Index Fds Vanguard Ultra (VUSB) | 0.6 | $2.7M | +9% | 55k | 49.55 |
|
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST) | 0.6 | $2.7M | +10% | 54k | 50.45 |
|
Ishares Tr Short Treas Bd (SHV) | 0.6 | $2.7M | 25k | 110.54 |
|
|
Solid Biosciences Com New (SLDB) | 0.6 | $2.7M | +20220% | 203k | 13.32 |
|
Wisdomtree Tr Floatng Rat Trea (USFR) | 0.6 | $2.7M | -5% | 53k | 50.29 |
|
Cellectar Biosciences Com New (CLRB) | 0.6 | $2.6M | -53% | 643k | 3.98 |
|
Omniab (OABI) | 0.6 | $2.4M | -5% | 452k | 5.42 |
|
Guardant Health (GH) | 0.5 | $2.4M | NEW | 117k | 20.63 |
|
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $2.3M | NEW | 207k | 11.30 |
|
Regeneron Pharmaceuticals (REGN) | 0.5 | $2.2M | NEW | 2.3k | 962.49 |
|
Ibio Con New (IBIO) | 0.5 | $2.2M | NEW | 600k | 3.65 |
|
Corteva (CTVA) | 0.5 | $2.2M | -35% | 37k | 57.67 |
|
Beyond Air (XAIR) | 0.5 | $2.1M | NEW | 1.2M | 1.74 |
|
Immunovant (IMVT) | 0.4 | $2.0M | -54% | 61k | 32.31 |
|
Ligand Pharmaceuticals Com New (LGND) | 0.4 | $2.0M | NEW | 27k | 73.10 |
|
Ssga Active Etf Tr Ult Sht Trm Bd (ULST) | 0.4 | $1.9M | -22% | 48k | 40.50 |
|
Spyre Therapeutics Com New (SYRE) | 0.4 | $1.9M | +668% | 50k | 37.93 |
|
Schrodinger (SDGR) | 0.4 | $1.7M | +3079% | 64k | 27.00 |
|
Spero Therapeutics (SPRO) | 0.4 | $1.6M | -13% | 927k | 1.72 |
|
Uniqure Nv SHS (QURE) | 0.3 | $1.5M | NEW | 293k | 5.20 |
|
Apellis Pharmaceuticals (APLS) | 0.3 | $1.5M | NEW | 26k | 58.78 |
|
Eli Lilly & Co. (LLY) | 0.3 | $1.5M | NEW | 1.9k | 777.96 |
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.3 | $1.4M | -8% | 102k | 14.11 |
|
Ngm Biopharmaceuticals | 0.3 | $1.3M | NEW | 817k | 1.59 |
|
Viking Therapeutics (VKTX) | 0.3 | $1.2M | -94% | 14k | 82.00 |
|
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $1.2M | -43% | 60k | 19.73 |
|
Envveno Medical (NVNO) | 0.2 | $1.1M | NEW | 202k | 5.44 |
|
Arvinas Ord (ARVN) | 0.2 | $1.1M | +3175% | 26k | 41.28 |
|
Delcath Sys Com New (DCTH) | 0.2 | $1.0M | -5% | 219k | 4.77 |
|
AngioDynamics (ANGO) | 0.2 | $900k | +15% | 153k | 5.87 |
|
Silence Therapeutics Ads (SLN) | 0.2 | $866k | +21000% | 40k | 21.60 |
|
Gossamer Bio (GOSS) | 0.2 | $865k | +2% | 733k | 1.18 |
|
Global Star Acquisition Class A Com (GLST) | 0.2 | $857k | 80k | 10.71 |
|
|
Voyager Therapeutics (VYGR) | 0.2 | $852k | -50% | 92k | 9.31 |
|
IsoRay (CATX) | 0.2 | $805k | +1503% | 677k | 1.19 |
|
Keen Vision Acquisition Corp Unit 99/99/9999 (KVACU) | 0.2 | $788k | 75k | 10.51 |
|
|
Actinium Pharmaceuticals (ATNM) | 0.2 | $783k | NEW | 100k | 7.83 |
|
Kiora Pharmaceuticals Com New | 0.2 | $777k | NEW | 1.1M | 0.71 |
|
Acasti Pharma Cl A (ACST) | 0.2 | $745k | +529% | 217k | 3.42 |
|
Morphic Hldg (MORF) | 0.2 | $694k | NEW | 20k | 35.20 |
|
Kymera Therapeutics (KYMR) | 0.1 | $643k | NEW | 16k | 40.20 |
|
Corbus Pharmaceuticals Hldgs Com New (CRBP) | 0.1 | $628k | NEW | 16k | 39.24 |
|
Therapeuticsmd Com New (TXMD) | 0.1 | $623k | 272k | 2.29 |
|
|
West Pharmaceutical Services (WST) | 0.1 | $594k | NEW | 1.5k | 395.71 |
|
Indivior Ord (INDV) | 0.1 | $591k | +14% | 28k | 21.42 |
|
Rhythm Pharmaceuticals (RYTM) | 0.1 | $537k | +1140% | 12k | 43.33 |
|
Tmt Acquisition Corp SHS (TMTC) | 0.1 | $535k | 50k | 10.69 |
|
|
Janux Therapeutics (JANX) | 0.1 | $527k | NEW | 14k | 37.65 |
|
Nurix Therapeutics (NRIX) | 0.1 | $523k | NEW | 36k | 14.70 |
|
Ab Active Etfs Ultra Short Incm (YEAR) | 0.1 | $505k | 10k | 50.52 |
|
|
Stevanato Group S P A Ord Shs (STVN) | 0.1 | $498k | NEW | 16k | 32.10 |
|
Pgim Etf Tr Pgim Ultra Sh Bd (PULS) | 0.1 | $497k | 10k | 49.70 |
|
|
Equillium (EQ) | 0.1 | $482k | +3111% | 209k | 2.31 |
|
Vistagen Therapeutics Ord (VTGN) | 0.1 | $475k | -63% | 90k | 5.28 |
|
Aerovate Therapeutics (AVTE) | 0.1 | $470k | NEW | 16k | 29.57 |
|
Tyra Biosciences (TYRA) | 0.1 | $464k | NEW | 28k | 16.40 |
|
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $460k | NEW | 41k | 11.23 |
|
Intelligent Bio Solutions In (INBS) | 0.1 | $457k | NEW | 108k | 4.22 |
|
Glycomimetics Put Option (GLYC) | 0.1 | $417k | NEW | 139k | 3.00 |
|
Amylyx Pharmaceuticals (AMLX) | 0.1 | $411k | +19% | 145k | 2.84 |
|
Apogee Therapeutics (APGE) | 0.1 | $399k | NEW | 6.0k | 66.45 |
|
Milestone Pharmaceuticals (MIST) | 0.1 | $362k | NEW | 203k | 1.79 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.1 | $359k | -88% | 14k | 24.90 |
|
Zai Lab Adr (ZLAB) | 0.1 | $352k | +10% | 22k | 16.02 |
|
Vyne Therapeutics (VYNE) | 0.1 | $338k | NEW | 110k | 3.07 |
|
Cytomx Therapeutics (CTMX) | 0.1 | $338k | NEW | 155k | 2.18 |
|
Oak Woods Acquisition Corp Cl A (OAKU) | 0.1 | $323k | 30k | 10.75 |
|
|
Screaming Eagle Acquisitn Class A Ord Shs | 0.1 | $321k | 30k | 10.70 |
|
|
Alector (ALEC) | 0.1 | $316k | NEW | 53k | 6.02 |
|
Mineralys Therapeutics (MLYS) | 0.1 | $310k | NEW | 24k | 12.91 |
|
Jvspac Acquisition Corp Unit 03/11/2024 (JVSAU) | 0.1 | $309k | NEW | 30k | 10.30 |
|
Alphabet Cap Stk Cl A (GOOGL) | 0.1 | $302k | NEW | 2.0k | 150.93 |
|
Spruce Biosciences (SPRB) | 0.1 | $287k | NEW | 365k | 0.79 |
|
Context Therapeutics (CNTX) | 0.1 | $284k | NEW | 206k | 1.38 |
|
Digital World Acquisition Co Class A Call Option (DJT) | 0.1 | $279k | NEW | 4.5k | 61.96 |
|
Sanofi Sponsored Adr (SNY) | 0.1 | $267k | NEW | 5.5k | 48.60 |
|
Tourmaline Bio (TRML) | 0.1 | $265k | NEW | 12k | 22.90 |
|
Cogent Communications Hldgs Com New (CCOI) | 0.1 | $261k | NEW | 4.0k | 65.33 |
|
Iron Horse Acquisitions Corp Unit 10/15/2028 (IROHU) | 0.1 | $255k | 25k | 10.19 |
|
|
Pimco Etf Tr 25yr+ Zero U S (ZROZ) | 0.1 | $238k | NEW | 3.0k | 79.25 |
|
Female Health (VERU) | 0.1 | $235k | -32% | 336k | 0.70 |
|
Option Care Health Com New (OPCH) | 0.1 | $235k | NEW | 7.0k | 33.54 |
|
Algonquin Power & Utilities equs (AQN) | 0.1 | $234k | -26% | 37k | 6.32 |
|
Abivax Sa Sponsored Ads (ABVX) | 0.0 | $215k | NEW | 15k | 14.30 |
|
Kezar Life Sciences (KZR) | 0.0 | $213k | NEW | 237k | 0.90 |
|
Pasithea Therapeutics Corp Com New (KTTA) | 0.0 | $201k | NEW | 28k | 7.25 |
|
Ishares Tr 20 Yr Tr Bd Etf (TLT) | 0.0 | $189k | NEW | 2.0k | 94.62 |
|
Wave Life Sciences SHS (WVE) | 0.0 | $185k | NEW | 30k | 6.17 |
|
Immatics SHS (IMTX) | 0.0 | $170k | -26% | 16k | 10.51 |
|
Greenlight Capital Re Class A (GLRE) | 0.0 | $167k | -60% | 13k | 12.47 |
|
Feutune Light Acquisition Cl A Com (FLFV) | 0.0 | $163k | 15k | 10.87 |
|
|
Abbott Laboratories (ABT) | 0.0 | $159k | NEW | 1.4k | 113.66 |
|
Nuvei Corporation Sub Vtg Shs (NVEI) | 0.0 | $158k | NEW | 5.0k | 31.62 |
|
Black Hawk Acquisition Corp Unit 99/99/9999 (BKHAU) | 0.0 | $152k | NEW | 15k | 10.15 |
|
Cabaletta Bio (CABA) | 0.0 | $152k | NEW | 8.9k | 17.06 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $151k | NEW | 3.0k | 50.23 |
|
Prothena Corp SHS (PRTA) | 0.0 | $148k | 6.0k | 24.77 |
|
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.0 | $141k | -17% | 3.3k | 42.86 |
|
Vaxcyte (PCVX) | 0.0 | $137k | +1900% | 2.0k | 68.31 |
|
McKesson Corporation (MCK) | 0.0 | $134k | NEW | 250.00 | 536.85 |
|
Gh Research Ordinary Shares (GHRS) | 0.0 | $134k | NEW | 13k | 10.66 |
|
Avalo Therapeutics Com New (AVTX) | 0.0 | $131k | NEW | 6.0k | 21.75 |
|
Ionis Pharmaceuticals (IONS) | 0.0 | $126k | NEW | 2.9k | 43.35 |
|
Taysha Gene Therapies Com Shs (TSHA) | 0.0 | $125k | -79% | 44k | 2.87 |
|
Biohaven (BHVN) | 0.0 | $120k | NEW | 2.2k | 54.69 |
|
Forte Biosciences (FBRX) | 0.0 | $119k | NEW | 171k | 0.70 |
|
Kalvista Pharmaceuticals (KALV) | 0.0 | $119k | NEW | 10k | 11.86 |
|
EXACT Sciences Corporation (EXAS) | 0.0 | $117k | NEW | 1.7k | 69.06 |
|
Organon & Co Common Stock (OGN) | 0.0 | $113k | NEW | 6.0k | 18.80 |
|
Jd.com Spon Adr Cl A (JD) | 0.0 | $110k | NEW | 4.0k | 27.39 |
|
Four Leaf Acquisition Corp Com Cl A (FORL) | 0.0 | $107k | 10k | 10.72 |
|
|
Acelyrin (SLRN) | 0.0 | $101k | +114% | 15k | 6.75 |
|
Longboard Pharmaceuticals In (LBPH) | 0.0 | $99k | +472% | 4.6k | 21.60 |
|
Kensington Capital Acquisiti Shs Cl A (KCGI) | 0.0 | $98k | 9.0k | 10.84 |
|
|
Lexaria Bioscience Corp Com New (LEXX) | 0.0 | $97k | +1537% | 27k | 3.63 |
|
Nextcure (NXTC) | 0.0 | $96k | -28% | 43k | 2.23 |
|
Bausch Plus Lomb Corp Common Shares (BLCO) | 0.0 | $92k | +51% | 5.3k | 17.30 |
|
Cg Oncology (CGON) | 0.0 | $90k | NEW | 2.1k | 43.90 |
|
Altria (MO) | 0.0 | $87k | -66% | 2.0k | 43.62 |
|
Mitek Sys Com New (MITK) | 0.0 | $79k | -26% | 5.6k | 14.10 |
|
99 Acquisition Group Unit 99/99/9999 (NNAGU) | 0.0 | $79k | 7.5k | 10.49 |
|
|
Ai Transn Acquisition Corp Unit 99/99/9999 (AITRU) | 0.0 | $78k | 7.5k | 10.42 |
|
|
Iovance Biotherapeutics (IOVA) | 0.0 | $74k | 5.0k | 14.82 |
|
|
Adicet Bio (ACET) | 0.0 | $73k | NEW | 31k | 2.35 |
|
Howard Hughes Holdings (HHH) | 0.0 | $73k | -66% | 1.0k | 72.62 |
|
Jasper Therapeutics Com New (JSPR) | 0.0 | $71k | NEW | 2.4k | 29.36 |
|
Anaptysbio Inc Common (ANAB) | 0.0 | $68k | NEW | 3.0k | 22.52 |
|
Rapt Therapeutics Put Option (RAPT) | 0.0 | $67k | 7.5k | 8.98 |
|
|
Tg Therapeutics (TGTX) | 0.0 | $66k | NEW | 4.4k | 15.21 |
|
Astria Therapeutics (ATXS) | 0.0 | $66k | -97% | 4.7k | 14.07 |
|
4d Molecular Therapeutics In (FDMT) | 0.0 | $64k | NEW | 2.0k | 31.86 |
|
Bausch Health Companies Call Option (BHC) | 0.0 | $64k | NEW | 6.0k | 10.61 |
|
Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $63k | -33% | 2.0k | 31.62 |
|
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.0 | $62k | NEW | 1.0k | 62.24 |
|
Evotec Sponsored Ads (EVO) | 0.0 | $60k | NEW | 7.7k | 7.83 |
|
Kohl's Corporation (KSS) | 0.0 | $58k | 2.0k | 29.15 |
|
|
Disc Medicine (IRON) | 0.0 | $56k | NEW | 896.00 | 62.26 |
|
Krystal Biotech (KRYS) | 0.0 | $53k | NEW | 300.00 | 177.93 |
|
Regenxbio Inc equity us cm (RGNX) | 0.0 | $53k | NEW | 2.5k | 21.07 |
|
Kraneshares Trust Csi Chi Internet (KWEB) | 0.0 | $53k | 2.0k | 26.25 |
|
|
Fibrogen (FGEN) | 0.0 | $50k | NEW | 21k | 2.35 |
|
Ovid Therapeutics (OVID) | 0.0 | $50k | +24% | 16k | 3.05 |
|
Ikena Oncology (IKNA) | 0.0 | $50k | NEW | 35k | 1.42 |
|
Amplify Energy Corp (AMPY) | 0.0 | $47k | 7.1k | 6.61 |
|
|
Pharvaris N V (PHVS) | 0.0 | $46k | NEW | 2.0k | 23.11 |
|
Insmed Com Par $.01 Put Option (INSM) | 0.0 | $46k | NEW | 1.7k | 27.13 |
|
Ultra Clean Holdings (UCTT) | 0.0 | $46k | NEW | 1.0k | 45.94 |
|
Akero Therapeutics (AKRO) | 0.0 | $46k | -88% | 1.8k | 25.26 |
|
Miragen Therapeutics (VRDN) | 0.0 | $45k | NEW | 2.6k | 17.51 |
|
Elevation Oncology (ELEV) | 0.0 | $44k | NEW | 8.6k | 5.13 |
|
Pyxis Oncology Common Stock (PYXS) | 0.0 | $43k | NEW | 10k | 4.26 |
|
Arcutis Biotherapeutics (ARQT) | 0.0 | $42k | -98% | 4.3k | 9.91 |
|
Denali Therapeutics (DNLI) | 0.0 | $41k | NEW | 2.0k | 20.52 |
|
Adverum Biotechnologies Com New (ADVM) | 0.0 | $40k | NEW | 2.8k | 14.14 |
|
Merck & Co (MRK) | 0.0 | $40k | -99% | 300.00 | 131.95 |
|
Stoke Therapeutics (STOK) | 0.0 | $39k | NEW | 2.9k | 13.50 |
|
Magnachip Semiconductor Corp (MX) | 0.0 | $39k | 7.0k | 5.58 |
|
|
Igm Biosciences (IGMS) | 0.0 | $39k | NEW | 4.0k | 9.65 |
|
Aslan Pharmaceuticals Spon Ads New (ASLN) | 0.0 | $37k | NEW | 59k | 0.62 |
|
89bio (ETNB) | 0.0 | $36k | +611% | 3.1k | 11.64 |
|
Hookipa Pharma Inc equity (HOOK) | 0.0 | $36k | NEW | 50k | 0.71 |
|
Neurogene (NGNE) | 0.0 | $34k | -87% | 661.00 | 50.90 |
|
Rallybio Corp (RLYB) | 0.0 | $33k | NEW | 18k | 1.85 |
|
Terns Pharmaceuticals (TERN) | 0.0 | $33k | -61% | 5.0k | 6.56 |
|
Amphastar Pharmaceuticals (AMPH) | 0.0 | $31k | NEW | 700.00 | 43.91 |
|
Liquidia Corporation Com New (LQDA) | 0.0 | $30k | NEW | 2.0k | 14.75 |
|
Design Therapeutics (DSGN) | 0.0 | $29k | +260% | 7.2k | 4.03 |
|
Cortexyme (QNCX) | 0.0 | $28k | NEW | 27k | 1.06 |
|
Savara (SVRA) | 0.0 | $28k | NEW | 5.6k | 4.98 |
|
Ventyx Biosciences (VTYX) | 0.0 | $28k | -61% | 5.0k | 5.50 |
|
Perrigo SHS (PRGO) | 0.0 | $26k | NEW | 800.00 | 32.19 |
|
NCR Corporation (VYX) | 0.0 | $25k | 2.0k | 12.63 |
|
|
Oncternal Therapeutics Com New (ONCT) | 0.0 | $22k | NEW | 2.5k | 9.00 |
|
Compass Therapeutics (CMPX) | 0.0 | $20k | NEW | 10k | 1.98 |
|
Zymeworks Del (ZYME) | 0.0 | $20k | NEW | 1.9k | 10.52 |
|
Ncr Atleos Corporation Com Shs (NATL) | 0.0 | $20k | 1.0k | 19.75 |
|
|
Akebia Therapeutics Put Option (AKBA) | 0.0 | $18k | NEW | 9.7k | 1.83 |
|
Arrowhead Pharmaceuticals (ARWR) | 0.0 | $17k | +100% | 600.00 | 28.60 |
|
Pmv Pharmaceuticals (PMVP) | 0.0 | $17k | NEW | 10k | 1.70 |
|
Astrazeneca Sponsored Adr (AZN) | 0.0 | $14k | NEW | 200.00 | 67.75 |
|
Steel Partners Hldgs Ltd Prtrship U (SPLP) | 0.0 | $14k | 341.00 | 39.65 |
|
|
Novo-nordisk A S Adr (NVO) | 0.0 | $13k | -98% | 100.00 | 128.40 |
|
Xeris Pharmaceuticals (XERS) | 0.0 | $11k | NEW | 5.1k | 2.21 |
|
Global Star Acquisition Right 06/21/2024 (GLSTR) | 0.0 | $11k | 118k | 0.09 |
|
|
Aurinia Pharmaceuticals (AUPH) | 0.0 | $10k | NEW | 2.0k | 5.01 |
|
ACADIA Pharmaceuticals (ACAD) | 0.0 | $9.2k | NEW | 500.00 | 18.49 |
|
Tmt Acquisition Corp Right 03/27/2028 (TMTCR) | 0.0 | $9.0k | 50k | 0.18 |
|
|
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.0 | $8.7k | NEW | 1.0k | 8.67 |
|
Dyne Therapeutics (DYN) | 0.0 | $8.4k | NEW | 297.00 | 28.39 |
|
Protara Therapeutics Com Stk (TARA) | 0.0 | $8.0k | -8% | 2.0k | 4.01 |
|
Surrozen Com New (SRZN) | 0.0 | $7.1k | NEW | 450.00 | 15.71 |
|
Bolt Biotherapeutics (BOLT) | 0.0 | $7.0k | NEW | 5.0k | 1.40 |
|
Bluebird Bio (BLUE) | 0.0 | $6.4k | NEW | 5.0k | 1.28 |
|
Oak Woods Acquisition Corp Right 03/23/2028 (OAKUR) | 0.0 | $6.0k | 30k | 0.20 |
|
|
Masimo Corporation (MASI) | 0.0 | $5.6k | -34% | 38.00 | 146.84 |
|
2seventy Bio Common Stock (TSVT) | 0.0 | $5.4k | 1.0k | 5.35 |
|
|
Addex Therapeutics Sponsored Ads (ADXN) | 0.0 | $5.0k | NEW | 390.00 | 12.80 |
|
Beyond Meat (BYND) | 0.0 | $4.8k | NEW | 577.00 | 8.28 |
|
Geron Corporation (GERN) | 0.0 | $4.3k | -92% | 1.3k | 3.30 |
|
Ichor Holdings SHS (ICHR) | 0.0 | $4.2k | NEW | 108.00 | 38.62 |
|
Calcimedica Com New (CALC) | 0.0 | $3.2k | NEW | 781.00 | 4.16 |
|
Relmada Therapeutics (RLMD) | 0.0 | $2.8k | -98% | 601.00 | 4.65 |
|
Talis Biomedical Corp Com New (TLIS) | 0.0 | $2.6k | NEW | 300.00 | 8.75 |
|
Embrace Change Acquisitn Cor Right 10/25/2026 (EMCGR) | 0.0 | $2.5k | 18k | 0.14 |
|
|
Karyopharm Therapeutics (KPTI) | 0.0 | $2.2k | NEW | 1.5k | 1.51 |
|
Global Star Acquisition *w Exp 07/15/202 (GLSTW) | 0.0 | $2.0k | 120k | 0.02 |
|
|
Feutune Light Acquisition Right 06/01/2029 (FLFVR) | 0.0 | $1.3k | 15k | 0.09 |
|
|
Futuretech Ii Acquisition *w Exp 08/18/202 (FTIIW) | 0.0 | $1.2k | 30k | 0.04 |
|
|
Ecd Automotive Design *w Exp 12/12/202 (ECDAW) | 0.0 | $818.159600 | 33k | 0.03 |
|
|
Travere Therapeutics (TVTX) | 0.0 | $771.000000 | 100.00 | 7.71 |
|
|
Pono Cap Two *w Exp 99/99/999 (PTWOW) | 0.0 | $693.000000 | 20k | 0.04 |
|
|
Cetus Cap Acquisition Corp Right 03/31/2024 (CETUR) | 0.0 | $604.879000 | 5.0k | 0.12 |
|
|
Oak Woods Acquisition Corp *w Exp 99/99/999 (OAKUW) | 0.0 | $600.000000 | 30k | 0.02 |
|
|
Feutune Light Acquisition *w Exp 06/01/202 (FLFVW) | 0.0 | $510.000000 | 15k | 0.03 |
|
|
Embrace Change Acquisitn Cor *w Exp 10/25/202 (EMCGW) | 0.0 | $406.800000 | 18k | 0.02 |
|
|
Four Leaf Acquisition Corp *w Exp 03/15/202 (FORLW) | 0.0 | $389.915700 | 9.5k | 0.04 |
|
|
Aimfinity Investment Corp I *w Exp 99/99/999 (AIMAW) | 0.0 | $234.000000 | 18k | 0.01 |
|
|
Cetus Cap Acquisition Corp *w Exp 01/31/202 (CETUW) | 0.0 | $95.000000 | 5.0k | 0.02 |
|
Past Filings by ADAR1 Capital Management
SEC 13F filings are viewable for ADAR1 Capital Management going back to 2023
- ADAR1 Capital Management 2024 Q1 filed May 15, 2024
- ADAR1 Capital Management 2023 Q4 filed Feb. 14, 2024